Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mod-NalIndependent statistical analysis of Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142818).
- Modeling Stress-precipitated Smoking Behavior for Medication Development: Complete Statistical AnalysisIndependent statistical analysis of Modeling Stress-precipitated Smoking Behavior for Medication Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00773357).
- Moderate to Severe Plaque Psoriasis With Scalp Involvement: Complete Statistical AnalysisIndependent statistical analysis of Moderate to Severe Plaque Psoriasis With Scalp Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00791765).
- MODERNIndependent statistical analysis of Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: Complete Statistical AnalysisIndependent statistical analysis of Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02806869).
- Modified Dakin’s Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modifying Cervical Bishop Scoring System: Complete Statistical AnalysisIndependent statistical analysis of Modifying Cervical Bishop Scoring System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02314260).
- Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders: Complete Statistical AnalysisIndependent statistical analysis of Modifying Physical Activity and Sedentary Time in Filipino Faith Leaders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03439852).
- ModOSAIndependent statistical analysis of Evaluation of Modafinil vs Placebo for Treatment of Anesthesia Delayed Emergence in Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01607450).
- Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00605904).
- MOHELIndependent statistical analysis of T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355679).
- Molecular-Guided Therapy for Childhood Cancer: Complete Statistical AnalysisIndependent statistical analysis of Molecular-Guided Therapy for Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02162732).
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): Complete Statistical AnalysisIndependent statistical analysis of Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01182350).
- MOLTIndependent statistical analysis of Mechanisms of Light-based Therapies for Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06004895).
- MOMSIndependent statistical analysis of Management of Myelomeningocele Study (MOMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00060606).
- Mona LisaIndependent statistical analysis of Clinical Evaluation of the GLYDe Dressing for Post-surgical Incision Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766727).
- MONALEESA-2Independent statistical analysis of Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MONARCH 1Independent statistical analysis of A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MONARCH plusIndependent statistical analysis of A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763566).
- Monitoring of Symptoms and Cognitive Function Using Telehealth: Complete Statistical AnalysisIndependent statistical analysis of Monitoring of Symptoms and Cognitive Function Using Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03184701).
- Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Monocyte Priming When Consuming a Western Diet: Complete Statistical AnalysisIndependent statistical analysis of Monocyte Priming When Consuming a Western Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05348395).
- Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549328).
- MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04204083).
- Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442559).
- Montelukast in Perennial Allergic Rhinitis – 2001-2002 Study (0476-246): Complete Statistical AnalysisIndependent statistical analysis of Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00974571).
- Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: Complete Statistical AnalysisIndependent statistical analysis of Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MORE-CAREIndependent statistical analysis of MOnitoring REsynchronization deviCes and cARdiac patiEnts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00885677).
- MORNDIABIndependent statistical analysis of Morbidity in Newly Diagnosed type2 Diabetes in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002091).
- MORPHEOIndependent statistical analysis of A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma: primary endpoint results, effect estimate…
- Morpheus LungIndependent statistical analysis of A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer): primary endpoint results, effect estimate with confidence interval,…
- Morphological Pattern of the Atrophic Posterior Maxillae: Complete Statistical AnalysisIndependent statistical analysis of Morphological Pattern of the Atrophic Posterior Maxillae: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02833337).
- MOST EMPOWERIndependent statistical analysis of MOST EMPOWER: Optimizing An Emotion Regulation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04317417).
- MOTIONIndependent statistical analysis of A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: Complete Statistical AnalysisIndependent statistical analysis of Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MOTIVATE-HFIndependent statistical analysis of MOTIVATional intErviewing to Improve Self-care in Heart Failure Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02894502).
- Motor Imagery Intervention for Improving Gait and Cognition in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Motor Imagery Intervention for Improving Gait and Cognition in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: Complete Statistical AnalysisIndependent statistical analysis of Motorized Continuous Cold Therapy Versus Standard Post-op Icing Protocol for Two Foot and Ankle Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MoTrPACIndependent statistical analysis of Molecular Transducers of Physical Activity Consortium (MoTrPAC) - Pediatric Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04151199).
- MOVEIndependent statistical analysis of Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels…
- Move For Your Health for Older Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Move For Your Health for Older Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05582889).
- MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MOVESIndependent statistical analysis of MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03820024).
- MOXIIndependent statistical analysis of Myogenic and Osteogenic Responses to eXercise and Ibuprofen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462722).
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180634).